Business News • MarketWire • Phibro Animal Health Corporation Announces Completion of the Sale of $275 Million of Notes, Early Settlement of Its Existing Series of Notes Tendered Pursuant to Its Tender Offers and Amendment of the Indentures Governing Such Existing Series of Notes Pursuant to Its Consent Solicitations

Phibro Animal Health Corporation Announces Completion of the Sale of $275 Million of Notes, Early Settlement of Its Existing Series of Notes Tendered Pursuant to Its Tender Offers and Amendment of the Indentures Governing Such Existing Series of Notes Pursuant to Its Consent Solicitations

Phibro Animal Health Corporation Announces Completion of the Sale of $275 Million of Notes, Early Settlement of Its Existing Series of Notes Tendered Pursuant to Its Tender Offers and Amendment of the Indentures Governing Such Existing Series of Notes Pursuant to Its Consent Solicitations

RIDGEFIELD PARK, NJ--(Marketwire - July 9, 2010) - Phibro Animal Health Corporation ("PAHC") announced today the successful consummation of the sale of $275 million of its 9 1/4% senior notes due 2018 in a private placement and resale under Rule 144A and Regulation S of the Securities Act of 1933, as amended.

View More : http://www.marketwire.com/mw/release.do?id=1287995&sourceType=3

Releted News by marketwire

Msambichaka and Sullivan Receive Minnesota Family Involvement Council Scholarships at TopLine Federal Credit Union

Complimentary Analyst Research on Google, Inc. (NASDAQ: GOOG), Baidu, Inc. (NASDAQ: BIDU), Dell, Inc. (NASDAQ: DELL), Microsoft Corp. (NASDAQ: MSFT) and Many More Available at Bedfordreport.com